Trial intelligence / Profile preview

The effect of atorvastatin therapy in COVID-19

IRCT20190831044653N5Phase 2Completed

Sponsor
North Khorasan University of Medical Sciences
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of atorvastatin in coronavirus disease 2019 (COVID-19), sponsored by North Khorasan University of Medical Sciences. Started Aug 2020; status: completed.

02

Drugs

atorvastatin
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on IRCT20190831044653N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190831044653N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call